Roundtable on Black in cancer research and oncology
Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe
Summary (AI generated)
And so, in this particular case, our goal is to refine and improve our systems and methods. This is an area of research that I focus on, as we are aware that cells communicate through different signaling pathways. Our aim is to ensure that these cells communicate with each other in a way that leads to sustained killing of abnormal cells. To illustrate, let's consider multiple Myeloma, a type of cancer that is currently being studied and developed. Unfortunately, it is not currently curable and mainly affects plasma cells in the bone marrow.
Our objective is to determine if CAR T cells, which are infused into the body, can continue to signal and communicate with each other. We want these cells to remain active long after they are introduced, so they can engage in immune surveillance and eliminate abnormal plasma cells. This information is crucial for those who seek a detailed understanding of the mechanisms involved. It is important to note that the immune system is typically triggered by certain cytokines in the body, which indicate the presence of a problem. For most individuals, this activation occurs in response to an infection.